Ex-Home Diagnostics CEO faces insider trading charges

The former chairman, president and CEO of Home Diagnostics is facing insider trading charges from federal prosecutors and the Securities & Exchange Commission, accusing him of tipping off friends and family to Nipro's $215 million acquisition of the diabetes monitoring equipment maker last year. News

Suggested Articles

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.

The company describes the continuous glucose monitor as the world’s smallest and thinnest diabetes sensor, with a disc about the size of two pennies.